Archive · 25 Sep 2025

Gene Therapy Shows Promise for Huntington's Disease

Gene Therapy Shows Promise for Huntington's Disease

Huntington's disease causes brain cell damage leading to movement and thinking problems.

A new gene therapy, AMT-130, has shown success in slowing the disease.

The treatment slowed the disease's progression by 75% over three years.

The therapy is delivered via brain surgery.

Patients could potentially live and work independently longer.

The FDA is expected to review data in 2026, and if approved, could launch in the next year.

This is the first treatment to slow the progression of the disease and offers hope to patients.

Sources